Kevin Marsh
KEMRI Wellcome Collaborative Research programme
Professor Kevin Marsh has a broad research interest in child health in the tropics, with a particular focus in the immune epidemiology of malaria. From 1989 to 2014 he directed the KEMRI Wellcome Programme in Kenya. Kevin's research interests focus on three main areas:
- Identifying the protective immune response to malaria
- Regulation of immune responses
- Determinants of virulence
Kevin has a particular interest is in the development of science in Africa. He is currently seconded for 50% of his time as senior adviser to the African Academy of Sciences. Kevin is chair of the WHO Malaria policy advisory committee (MPAC) and a member of many global health advisory groups.
Recent publications
Uncovering the genetic diversity of the malaria parasite antigen MSP2 across Sub-Saharan Africa
Preprint
Zerebinski J. et al, (2025)
Doxycycline for the treatment of nodding syndrome: a randomised, placebo-controlled, phase 2 trial.
Journal article
Idro R. et al, (2024), The Lancet. Global health, 12, e1149 - e1158
Mortality in rural coastal Kenya measured using the Kilifi Health and Demographic Surveillance System: a 16-year descriptive analysis
Journal article
Otiende M. et al, (2023), Wellcome Open Research, 6, 327 - 327
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
Journal article
Abdel Hamid MM. et al, (2023), Wellcome Open Research, 8, 22 - 22
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.
Journal article
MalariaGEN . et al, (2023), Wellcome open research, 8